Genmab A/S
F:GE9
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Genmab A/S
F:GE9
|
DK |
|
A
|
Arix Bioscience PLC
F:3HY
|
UK |
|
A
|
ACM Research Inc
F:813
|
US |
Intrinsic Value
The intrinsic value for 
Genmab A/S (GE9) under the Base Case is 65.15 EUR.
Compared with the current market price of 212.3 EUR, the stock appears
Overvalued by 69% .
Both DCF and multiples point to overvaluation.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Genmab A/S.
Fundamental Analysis
Revenue & Expenses Breakdown
Genmab A/S
Earnings Waterfall
Genmab A/S
The intrinsic value for Genmab A/S (GE9) under the Base Case is 65.15 EUR.
Compared with the current market price of 212.3 EUR, the stock appears Overvalued by 69% .
